Wednesday, 14 October 20267:16 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

BNTX Stock Selloff Deepens Doubts: BMO Ties BNT113 Miss To Wider mRNA Cancer Vaccine Struggles

Image: Asianet Newsable. Rights remain with the publisher.

BMO Capital Markets analyst Evan David Seigerman said that the PFS miss for BNT113 “adds to a growing list of recent mRNA cancer vaccine setbacks” and is likely to pressure the stock.

Read the full report on Asianet Newsable

Story file

Section
Health
Topics
Health alerts
First reported by
Asianet Newsable
Reporter
stocktwits inc
Published
Wednesday, 14 October 2026, 5:00 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all